BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T110000
DTEND;TZID=America/New_York:20230531T120000
DTSTAMP:20260501T160204
CREATED:20230512T193733Z
LAST-MODIFIED:20230512T193835Z
UID:3834-1685530800-1685534400@www.mdtechcouncil.com
SUMMARY:T Cell Receptor Targeting CD22 for the Treatment of Lymphomas and Leukemias
DESCRIPTION:Register to attend a free NIH webinar. Attendees will learn about a new T-cell receptor (TCR) that targets CD22\, being developed by the National Cancer Institute (NCI) as a cellular immunotherapy to treat lymphomas and leukemias. CD22 TCR-T cells clear leukemia at clinically relevant doses without causing systemic cytokine elevation. \nThe webinar will highlight: \n\nNovel CD22 specific TCR-T cells reducing tumor burden at clinically relevant doses\n\nA new therapeutic method using these novel CD22 specific TCR-T cells that overcomes current treatment limitations for hematologic malignancies. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/t-cell-receptor-targeting-cd22-for-the-treatment-of-lymphomas-and-leukemias/
LOCATION:Virtual Event
ORGANIZER;CN="NIH%7CNCI%20Tech%20Transfer%20Center":MAILTO:rouault@mail.nih.gov
END:VEVENT
END:VCALENDAR